Published in

Elsevier, Lung Cancer, (124), p. 179-188

DOI: 10.1016/j.lungcan.2018.08.012

Links

Tools

Export citation

Search in Google Scholar

Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO